Price Chart

Price Chart

Profile

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
URL http://www.billiontoone.com
Investor Relations URL N/A
HQ State/Province California
Sector Health Care
Industry Health Care Providers & Services
Equity Style Small Cap Growth
Next Earnings Release Nov. 05, 2026 (est.)
Last Earnings Release Aug. 05, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
URL http://www.billiontoone.com
Investor Relations URL N/A
HQ State/Province California
Sector Health Care
Industry Health Care Providers & Services
Equity Style Small Cap Growth
Next Earnings Release Nov. 05, 2026 (est.)
Last Earnings Release Aug. 05, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A